Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
8.28
+0.01 (0.06%)
Dec 3, 2025, 12:07 PM EST - Market open
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $17.18 million as of December 3, 2025. Its market cap has decreased by -41.84% in one year.
Market Cap
17.18M
Enterprise Value
13.31M
1-Year Change
-41.84%
Ranking
Category
Stock Price
$8.28
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $17.18M, a decrease of -70.47%. That is a compound annual growth rate of -34.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2025 | 17.17M | -33.53% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
| Jan 20, 2023 | 58.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |